Blood Test For Breast Cancer

Breast Cancer: Some Statisticsbrink of being available on a widespread scale. It
Every year, over 1.1 million women worldwide receivereplaces mammography with a blood test. Specifically,
the unwelcome diagnosis of breast cancer, a figurethe test seeks traces of certain proteins (tumor
which has virtually doubled since 1975 and appears toantigens) in the blood. These proteins are uniquely
be likely to increase in the foreseeable future. In thecorrelated with specific types of breast cancer. The
Unites States, breast cancer is the second mostnew test may well prove to be considerably more
common form of cancer (preceded only by skinreliable than mammography, promising to detect
cancer), affecting 250,000 women annually. It is thecancerous tissue changes at the very earliest stages,
second most common cause of cancer death,when treatment is most likely to be effective. Any
accounting for 40,170 deaths each year - only deathselevation of these blood markers above normal
from lung cancer are more common in the USconcentrations is likely to be a sign that early
population. It undoubtedly constitutes a most pressingchanges are underway, and the test appears to be
public health priority and, with epidemiological data likehighly sensitive in detecting these alterations in blood
this, many have argued that universal breast cancerbiochemistry. Researchers who are developing the
screening for all women at least annually should betest are optimistic that it will detect cellular
the norm. However, on closer inspection, this mayabnormalities significantly earlier than mammograms,
not be the best or the safest means of preventingby sensing miniscule shifts in cancer protein marker
the disease.levels.
The Disadvantages of MammogramsThe test is known as 'BC-SeraPro' and is already
This may seem like a rather callous assertion, andyielding impressive results in clinical trials, showing a
anyone who has received successful treatment for95% success rate. To be precise, it measures the
cancer after a mammogram-detected tissuepresence of no less than 22 tumor antigens (or
abnormality is likely to think it bizarre, but the fact of'biomarkers') in serum, providing a reliable
the matter is that mammograms themselves aredifferentiation between breast cancer sufferers and
neither wholly reliable nor risk free, and may behealthy patients. Developed and evaluated by Power3
especially risky for women who have a higher risk ofMedical Laboratories, the test appears to be highly
developing the disease due to genetic factors.accurate, safe and non-invasive. By contrast, women
Frequently, an ambiguous result emerges suggestingusually find mammograms painful and uncomfortable,
a 'probably benign' lesion, an outcome which placesas the procedure necessarily involves squeezing and
both physician and patient in a real quandary. Suchflattening the breast in order to obtain a clear image;
patients are often referred for repeatmore body conscious individuals also find exposing the
mammographies. Mammograms also are prone tobreast an awkward and embarrassing ritual. The
produce both false positives (causing unnecessaryblood test clearly dispenses with these problems and
distress and alarm) and false negatives (with an eventotally protects women from exposure to potentially
worse predicament for the patient who believes thatharmful ionizing radiation. It is expected that the U.S.
they are healthy when, indeed, they may not be).Food and Drug Administration will approve the test
Mammograms use ionizing radiation to detect tissuefor use during the early part of 2010, after which it
changes in the breast which physical examinationshould quickly become available to the general public.
alone would not be able to find; that is their strengthA closely allied test, developed by Provista Life
and also their weakness. For example, one study hasSciences, is already available and is known as the
suggested that some women with a geneticBiomarker Translation Test (or BT Test for short).
predisposition for breast cancer who are subjectedSimilar to Power3's BC-SeraPro, it detects multiple
to quite low doses of ionizing radiation duringserum-based biomarkers for breast cancer in blood
mammogram screening may be significantly more atsamples. Used in conjunction with a medical profile of
risk of developing cancer as a result. Young womenthe patient, the individual test result is analyzed by a
aged between 25 and 29 who carried a variant ofproprietary data analysis procedure which produces a
the BRCA gene (which mutates its normal functionscore (known as the BT Score) which accurately
and predisposes the bearers of the gene to breastindicates the presence or absence of breast cancer.
cancer) were found to receive no benefit fromPresently, the results suggest that the test is
mammography but an increased risk of setting thesomewhere in the vicinity of 80% accurate, and
illness off.efforts to improve this accuracy rate are currently
This was a mathematical modeling study but otherongoing.
physicians share the concerns about the indiscriminateIs This a Significant Step Forward in the Fight Against
use of mammograms as a screening instrument, withBreast Cancer?
one specialist claiming that as many 75% of cases ofDesigned originally simply to be another 'tool in the
breast cancer could be prevented by reducing orphysician's box' to complement prevailing imaging
wholly avoiding mammography and X-rays amongsttechniques, the test is promising to become a major
women vulnerable to the illness. Clearly, if a meansnew diagnostic asset. It may be a little too early to
could be devised which permitted accurate earlysay at this point - the BT Test is available in 41
diagnosis of breast cancer with none of the harmfulStates, in 27 of which the test can be sent directly
effects of ionizing radiation, it would be a mostto consumers without physician prescription - but
welcome and valuable development in the fightthese new blood tests for breast cancer may prove
against this dreadful disease.to be a substantial asset in the ongoing battle to
A Diagnostic Alternativebeat this terrible, distressing and all-too-often tragic
Thankfully, such a means appears to be on the veryillness.